Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Palliative Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 6 Neoplasm Metastasis 5 Colorectal Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Motor Activity 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Fatigue 2 Thyroid Neoplasms 1 Stress Disorders, Post-Traumatic 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Signs and Symptoms 1 Sarcoma 1 Rectal Neoplasms 1 Penile Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Neoplasm 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Rituximab 41 Cyclophosphamide 39 Prednisone 26 Doxorubicin 23 Vincristine 19 Magnetic Resonance Spectroscopy 17 polatuzumab vedotin 16 Specimen Handling 16 Lenalidomide 16 Gemcitabine 16 fludarabine 14 Oxaliplatin 13 CT-P10 13 Biopsy 11 glofitamab 10 obinutuzumab 9 Etoposide 9 venetoclax 8 ibrutinib 8 deltacortene 8 Immunotherapy, Adoptive 8 prednylidene 7 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 axicabtagene ciloleucel 6 Leukapheresis 6 zanubrutinib 5 fludarabine phosphate 5 acalabrutinib 5 R-CHOP protocol 5 Prednisolone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡